Prostate cancer diagnosis relies on a core needle biopsy (CNB) of the prostate, typically performed on patients with elevated prostate-specific antigen (PSA) levels in their blood or an abnormal digital rectal examination. The gene discussed is KLK3; the disease is prostate cancer.